المؤلفون: Orellana-Noia, VM, Reed, DR, McCook, AA, Sen, JM, Barlow, CM, Malecek, M-K, Watkins, M, Kahl, BS, Spinner, MA, Advani, R, Voorhees, TJ, Snow, A, Grover, NS, Ayers, A, Romancik, JT, Liu, Y, Huntington, SF, Chavez, JC, Saeed, H, Lazaryan, A, Raghunathan, V, Spurgeon, SE, Ollila, TA, Del Prete, C, Olszewski, AJ, Ayers, EC, Landsburg, DJ, Echalier, B, Lee, J, Kamdar, M, Caimi, PF, Fu, T, Liu, J, David, KA, Alharthy, H, Law, J, Karmali, R, Shah, H, Stephens, DM, Major, A, Rojek, AE, Smith, SM, Yellala, A, Kallam, A, Nakhoda, S, Khan, N, Sohail, MA, Hill, BT, Barrett-Campbell, O, Lansigan, F, Switchenko, J, Cohen, JB, Portell, CA

المصدر: Blood; 20210101, Issue: Preprints

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Spinner MA; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, USA., Advani RH; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, USA.

المصدر: Expert opinion on emerging drugs [Expert Opin Emerg Drugs] 2024 May 06, pp. 1-13. Date of Electronic Publication: 2024 May 06.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101135662 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7623 (Electronic) Linking ISSN: 14728214 NLM ISO Abbreviation: Expert Opin Emerg Drugs Subsets: MEDLINE

المؤلفون: Desai SH; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN.; Division of Hematology, Mayo Clinic, Rochester, MN., Spinner MA; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA., Evens AM; Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Sykorova A; University Hospital and Faculty of Medicine, Hradec Kralove, Hradec Kralove, Czech Republic., Bachanova V; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN., Goyal G; Division of Hematology & Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL., Kahl B; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO., Dorritie K; Division of Hematology & Oncology, Department of Medicine, UPMC Hillman Cancer Center, Pittsburgh, PA., Azzi J; Icahn School of Medicine Mount Sinai, New York, NY., Kenkre VP; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin, Madison, WI., Chang C; Division of Oncology, Department of Medicine, Stanford University Medical Center, Stanford, CA., Michalka J; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Ansell SM; Division of Hematology, Mayo Clinic, Rochester, MN., Fusco B; Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Sumransub N; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN., Hatic H; Division of Hematology & Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL., Saba R; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO., Ibrahim U; Icahn School of Medicine Mount Sinai, New York, NY., Harris EI; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin, Madison, WI., Shah H; Division of Hematology, Department of Medicine, Hunstman Cancer Institute, The University of Utah, Salt Lake City, UT., Wagner-Johnston N; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD., Arai S; Division of Oncology, Department of Medicine, Stanford University Medical Center, Stanford, CA., Nowakowski GS; Division of Hematology, Mayo Clinic, Rochester, MN., Mocikova H; Department of Clinical Hematology, Charles University in Prague, Prague, Czech Republic., Jagadeesh D; Cleveland Clinic Foundation, Cleveland, OH., Blum KA; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA., Diefenbach C; Perlmutter Cancer Center, NYU Grossman Medical School, New York, NY., Iyengar S; Division of Hematology, Department of Medicine, Hunstman Cancer Institute, The University of Utah, Salt Lake City, UT., Rappazzo KC; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD., Baidoun F; Cleveland Clinic Foundation, Cleveland, OH., Choi Y; Perlmutter Cancer Center, NYU Grossman Medical School, New York, NY., Prochazka V; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Czech Republic., Advani RH; Division of Oncology, Department of Medicine, Stanford University Medical Center, Stanford, CA., Micallef I; Division of Hematology, Mayo Clinic, Rochester, MN.

المصدر: Blood advances [Blood Adv] 2023 Dec 12; Vol. 7 (23), pp. 7295-7303.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Hodgkin Disease*/therapy , Immunoconjugates*, Adult ; Female ; Humans ; Male ; Brentuximab Vedotin ; Retrospective Studies ; Stem Cell Transplantation ; Middle Aged

المؤلفون: Spinner MA; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA., Komanduri KV; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2023 Dec; Vol. 29 (12), pp. 725-726.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Chimeric Antigen* , Lymphoma*/therapy, Humans ; Immunotherapy, Adoptive ; Transplantation, Homologous ; Survivors

المؤلفون: Bowers JT; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Anna J; Division of Hematology, University of Colorado Denver, Aurora, CO., Bair SM; Division of Hematology, University of Colorado Denver, Aurora, CO., Annunzio K; The Ohio State University, Columbus, OH., Epperla N; The Ohio State University, Columbus, OH., Pullukkara JJ; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Gaballa S; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Spinner MA; Division of Hematology Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA., Li S; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA., Messmer MR; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA., Nguyen J; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA., Ayers EC; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA., Wagner CB; Division of Hematology/Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Hu B; Division of Hematology/Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Di M; Division of Hematology Oncology, Department of Medicine, Yale University, New Haven, CT., Huntington SF; Division of Hematology Oncology, Department of Medicine, Yale University, New Haven, CT., Furqan F; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI., Shah NN; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI., Chen C; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Ballard HJ; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Hughes ME; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Chong EA; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Nasta SD; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Barta SK; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Landsburg DJ; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Svoboda J; Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA.

المصدر: Blood advances [Blood Adv] 2023 Nov 14; Vol. 7 (21), pp. 6630-6638.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Hodgkin Disease*/complications , Hodgkin Disease*/drug therapy , Hodgkin Disease*/pathology , Peripheral Nervous System Diseases*/etiology , Peripheral Nervous System Diseases*/chemically induced, Humans ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Brentuximab Vedotin/therapeutic use ; Incidence ; Retrospective Studies

المؤلفون: Randall MP; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA., Spinner MA; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.

المصدر: Cancers [Cancers (Basel)] 2023 Sep 11; Vol. 15 (18). Date of Electronic Publication: 2023 Sep 11.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Spinner MA; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA.; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA., Sica RA; Division of Oncology, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY., Tamaresis JS; Department of Biomedical Data Science, Stanford University, Stanford, CA., Lu Y; Department of Biomedical Data Science, Stanford University, Stanford, CA., Chang C; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Lowsky R; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Frank MJ; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Johnston LJ; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Miklos DB; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Muffly LS; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Negrin RS; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Rezvani AR; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Shiraz P; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Shizuru JA; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Weng WK; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Binkley MS; Department of Radiation Oncology, Stanford University, Stanford, CA., Hoppe RT; Department of Radiation Oncology, Stanford University, Stanford, CA., Advani RH; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Arai S; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA.

المصدر: Blood [Blood] 2023 Jun 01; Vol. 141 (22), pp. 2727-2737.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Hodgkin Disease*/pathology , Hematopoietic Stem Cell Transplantation*/adverse effects, Humans ; Middle Aged ; Transplantation, Autologous ; Immune Checkpoint Inhibitors/therapeutic use ; Neoplasm Recurrence, Local/therapy ; Brentuximab Vedotin/therapeutic use

المؤلفون: Desai SH; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, USA., Spinner MA; Division of Oncology, Department of Medicine, Stanford University Medical Center, Stanford, California, USA., David K; Department of Hematology and Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Bachanova V; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, USA.; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Goyal G; O'Neal Comprehensive Cancer Center, University of Alabama, Birmingham, Alabama, USA., Kahl B; Division of Hematology and Oncology, Washington University School of Medicine, St. Louis, Missouri, USA., Dorritie K; Division of Hematology-Oncology, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Azzi J; Division of Hematology and Medical Oncology, Icahn School of Medicine Mount Sinai, New York, New York, USA., Kenkre VP; Department of Hematology, University of Wisconsin, Madison, Wisconsin, USA., Arai S; Division of Oncology, Department of Medicine, Stanford University Medical Center, Stanford, California, USA., Chang C; Division of Oncology, Department of Medicine, Stanford University Medical Center, Stanford, California, USA., Fusco B; Department of Hematology and Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Sumransub N; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, USA.; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Hatic H; O'Neal Comprehensive Cancer Center, University of Alabama, Birmingham, Alabama, USA., Saba R; Division of Hematology and Oncology, Washington University School of Medicine, St. Louis, Missouri, USA., Ibrahim U; Division of Hematology and Medical Oncology, Icahn School of Medicine Mount Sinai, New York, New York, USA., Harris EI; Department of Hematology, University of Wisconsin, Madison, Wisconsin, USA., Shah H; Division of Hematology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Murphy J; Department of Oncology, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA., Ansell S; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Jagadish D; Cleveland Clinic Foundation, Cleveland, Ohio, USA., Orellana-Noia V; Division of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Diefenbach C; Perlmutter Cancer Center, NYU Grossman Medical School, New York, New York, USA., Iyenger S; Division of Hematology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Rappazzo KC; Department of Oncology, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA., Mishra R; Cleveland Clinic Foundation, Cleveland, Ohio, USA., Choi Y; Perlmutter Cancer Center, NYU Grossman Medical School, New York, New York, USA., Nowakowski GS; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Advani RH; Division of Oncology, Department of Medicine, Stanford University Medical Center, Stanford, California, USA., Micallef IN; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.

المصدر: American journal of hematology [Am J Hematol] 2023 Mar; Vol. 98 (3), pp. 464-471. Date of Electronic Publication: 2023 Jan 11.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Hodgkin Disease*/drug therapy , Hodgkin Disease*/pathology , Hematopoietic Stem Cell Transplantation*, Humans ; Progression-Free Survival ; Retrospective Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Brentuximab Vedotin/therapeutic use ; Stem Cell Transplantation ; Transplantation, Autologous ; Salvage Therapy

المؤلفون: Hamid MS; University of Tennessee Health Science Center, Memphis, TN. Electronic address: mhamid2@uthsc.edu., Rutherford SC; Weill Cornell Medicine, New York City, NY., Jang H; Karmanos Cancer Institute, Detroit, MI., Kim S; Karmanos Cancer Institute, Detroit, MI., Patel K; Swedish Cancer Institute, Seattle, WA., Bartlett NL; Washington University Medical University at St. Louis, St. Louis, MO., Malecek MK; Washington University Medical University at St. Louis, St. Louis, MO., Watkins MP; Washington University Medical University at St. Louis, St. Louis, MO., Maddocks KJ; The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH., Bond DA; The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH., Feldman TA; John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, NJ., Magarelli G; John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, NJ., Advani RH; Stanford Cancer Institute at Stanford University, Stanford, CA., Spinner MA; Stanford Cancer Institute at Stanford University, Stanford, CA., Evens AM; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Shah M; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Ahmed S; MD Anderson Cancer Center, Houston, TX., Stephens DM; Huntsman Cancer Institute at University of Utah, Salt Lake City, UT., Allen P; Winship Cancer Institute at Emory University, Atlanta, GA., Tees MT; Colorado Blood Cancer Institute, Denver, CO., Karmali R; Northwestern University, Chicago, IL., Cheson BD; Lombardi Comprehensive Cancer Center, Washington D.C., Yazdy MS; Lombardi Comprehensive Cancer Center, Washington D.C., Strouse C; University of Iowa, Iowa City, IA., Bailey NA; Swedish Cancer Institute, Seattle, WA., Pagel JM; Swedish Cancer Institute, Seattle, WA., Ramchandren R; University of Tennessee Medical Center, Knoxville TN.

المصدر: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Jul; Vol. 22 (7), pp. e435-e442. Date of Electronic Publication: 2021 Dec 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

مواضيع طبية MeSH: Hodgkin Disease*/diagnostic imaging , Hodgkin Disease*/drug therapy , Hodgkin Disease*/pathology, Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bleomycin/therapeutic use ; Dacarbazine/therapeutic use ; Doxorubicin/therapeutic use ; Humans ; Positron-Emission Tomography/methods ; Vinblastine/therapeutic use